Analyst firms · Deutsche Bank · CME
Deutsche Bank CME price target and rating history
CME Group Inc. (CME) · Finance
Deutsche Bank rates CME Group Inc. (CME) Hold with a $270 price target, as of its latest action on Aug 19, 2026. It has published 4 rating actions on CME since February 2022, including 2 upgrades and 1 downgrade. Across 5 firms with a CME price target in the last 12 months, the median target is $305. Deutsche Bank's $270 is 11% below that.
- Current rating
- Hold
- Price target
- $270
- Median target, all firms
- $305
- Actions on CME
- 4
Deutsche Bank price target on CME
Every Deutsche Bank rating on CME
- Aug 19, 2026
- Oct 23, 2025
- Oct 12, 2022
- Feb 10, 2022
How other firms rate CME
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Overweight | $301 | Oct 2, 2026 |
| Deutsche Bank | Hold | $270 | Aug 19, 2026 |
| Keefe, Bruyette & Woods | Outperform | $305 | Jun 18, 2026 |
| Rothschild & Co Redburn | Buy | $323 | Jun 11, 2026 |
| Erste Group | Hold | Jun 5, 2026 | |
| Argus Research | Hold | Mar 4, 2026 | |
| TD Cowen | Buy | $305 | Jan 14, 2026 |
Questions about Deutsche Bank and CME
- What is Deutsche Bank's price target for CME?
- Deutsche Bank's latest stated price target for CME Group Inc. (CME) is $270, from its action on Aug 19, 2026.
- What is Deutsche Bank's rating on CME?
- Deutsche Bank rates CME Hold, a neutral rating, as of Aug 19, 2026.
- When did Deutsche Bank last change its view on CME?
- On Aug 19, 2026, Deutsche Bank downgrades to Hold from Buy, price target $270.
- How does Deutsche Bank's CME target compare with other analysts?
- Across 5 firms with a CME price target in the last 12 months, the median target is $305. Deutsche Bank's $270 is 11% below that.
More CME rating histories
All Deutsche Bank ratingsCME news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.